The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
β Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial Infarction: The ECTIM Study
Abstract
Background Polymorphisms of the β fibrinogen gene have been shown to affect plasma fibrinogen levels and the risk of peripheral arterial disease. We now present the results of a detailed analysis of the β fibrinogen gene in relation to plasma fibrinogen and to the severity of coronary artery disease (CAD) in patients with myocardial infarction (MI) in the ECTIM Study. Methods and Results Ten polymorphisms of the β fibrinogen gene, including five new polymorphisms identified by single-strand conformation polymorphism analysis, and one polymorphism in the 3′ flanking region of the α fibrinogen gene were investigated in 565 patients with MI and 668 control subjects. The polymorphisms were in tight linkage disequilibrium and the genotype frequencies were similar in patients with MI and control subjects. In the multivariate analysis, only two polymorphisms, β Hae III ( P <.0003) and β-854 ( P <.01), were independently associated with plasma fibrinogen. The significant association between β fibrinogen polymorphisms and plasma fibrinogen was present in smokers but not in nonsmokers. In French MI patients, the number of coronary arteries with >50% stenosis was estimated by angiography and used as a criterion for severity of CAD. Presence of the less frequent allele of the β Bcl I ( P <.0003) and of other polymorphisms was positively associated with the severity of CAD. Conclusions Genetic variants of the β fibrinogen gene are associated with an increased plasma level of fibrinogen, especially in smokers. The association with CAD appears to be the consequence of an increased risk of MI in subjects with severe CAD who carry the predisposing β fibrinogen genotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Molecular Evolutionary Genetics
Nei, M. (1987) · Columbia University Press eBooks · doi:10.7312/nei-92038 · Cited by 15,271
Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., & Sekiya, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2766 · Cited by 3,610
Meade, T. W., Brozovic, M., Chakrabarti, R. R., Haines, A. P., Imeson, J. D., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,939
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Saiki, R. K., Bugawan, T. L., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1986) · Nature · doi:10.1038/324163a0 · Cited by 1,827
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,646
Yarnell, J. W., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., Whitehead, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 916
Fibrinogen and Risk of Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 886
PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA.
Hayashi, K. (1991) · Genome Research · doi:10.1101/gr.1.1.34 · Cited by 756
Heinrich, J., Balleisen, L., Schulte, H., Assmann, G., & van de Loo, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.54 · Cited by 563
Atherosclerotic plaque rupture and thrombosis. Evolving concepts.
Fuster, V., Stein, B., Ambrose, J. A., Badimón, L., Badimón, J. J., & Chesebro, J. H. (1990) · PubMed · Cited by 454
Plasma fibrinogen--a major coronary risk factor.
Stone, M. C., & Thorp, J. M. (1985) · PubMed · Cited by 362
Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita)
George, A. L., Crackower, M. A., Abdalla, J. A., Hudson, A. J., & Ebers, G. C. (1993) · Nature Genetics · doi:10.1038/ng0493-305 · Cited by 283
Parra, H. J., Arveiler, D., Evans, A. E., Cambou, J. P., Amouyel, P., Bingham, A., McMaster, D., Schaffer, P., Douste-Blazy, P., & Luc, G. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.701 · Cited by 233
Self-citationHumphries, S. E., Dubowitz, M., Cook, M., Stirling, Y., & Meade, T. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92205-7 · Cited by 231
Fate of fibrinogen in human arterial intima.
Smith, E. B., Keen, G. A., Grant, A., & Stirk, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.263 · Cited by 197
Qizilbash, N., Jones, L., Warlow, C., & Mann, J. (1991) · BMJ · doi:10.1136/bmj.303.6803.605 · Cited by 184
Thomas, A. E., Green, F. R., Kelleher, C. H., Wilkes, H. C., Brennan, P. J., Meade, T. W., & Humphries, S. E. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648177 · Cited by 172
Self-citationDalmon, J., Laurent, M., & Courtois, G. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.1183-1193.1993 · Cited by 171
Fibrinogen genotype and risk of peripheral atherosclerosis
Fowkes, F. G. R., Smith, F. B., Donnan, P. T., Connor, J. M., Wood, J., & Lowe, G. D. O. (1992) · The Lancet · doi:10.1016/0140-6736(92)90596-u · Cited by 134
Roy, S., Mukhopadhyay, G., & Redman, C. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39338-x · Cited by 132
Epidemiology of peripheral vascular disease
Fowkes, F. G. R. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06122-4 · Cited by 128
Green, F. R., Hamsten, A., Blombäck, M., & Humphries, S. E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649699 · Cited by 127
Self-citationScarabin, P., Bara, L., Ricard, S., Poirier, O., Cambou, J., Arveiler, D., Luc, G., Evans, A. E., Samama, M. M., & Cambien, F. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.886 · Cited by 123
Self-citationGreen, F. R., Hamsten, A., Blombäck, M., & Humphries, S. E. (1993) · PubMed · Cited by 113
Self-citationThomas, A. E., Lamlum, H., Humphries, S. E., & Green, F. R. (1994) · Human Mutation · doi:10.1002/humu.1380030117 · Cited by 99
Self-citationHuber, P., Laurent, M., & Dalmon, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39419-0 · Cited by 95
Baumann, R., & Henschen-Edman, A. H. (1993) · Blood · doi:10.1182/blood.v82.7.2117.2117 · Cited by 91
Dalmon, J., Laurent, M., & Courtois, G. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.1183 · Cited by 91
Bara, L., Nicaud, V., Tiret, L., Cambien, F., Samama, M. M., & On behalf of the EARS group (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642456 · Cited by 50
Self-citationDunning, A. M., Renges, H.-H., Xu, C., Peacock, R. E., Brasseur, R., Laxer, G., Tikkanen, M., Bütler, R., Saha, N., & Hamsten, A. (1992) · Europe PMC (PubMed Central) · Cited by 41
Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales.
Yarnell, J. W. G., FEHILY, A. M., Milbank, J., Kubicki, A. J., Eastham, R. D., & Hayes, T. M. (1983) · Journal of Epidemiology & Community Health · doi:10.1136/jech.37.2.137 · Cited by 38
Gurewich, V., Lipiński, B., & Hyde, E. (1976) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648080 · Cited by 37
Characterization of the 5′-flanking region for the human fibrinogen β gene
Huber, P., Dalmon, J., Courtois, G., Laurent, M., Assouline, Z., & Marguerie, G. A. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.4.1615 · Cited by 23
Cited by
Wood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,255
Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction
Rosenson, R. S., & Tangney, C. C. (1998) · JAMA · doi:10.1001/jama.279.20.1643 · Cited by 954
Zhang, B., Ye, S., Herrmann, S.-M., Eriksson, P., de Maat, M., Evans, A., Arveiler, D., Luc, G., Cambien, F., Hamsten, A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.14.1788 · Cited by 611
Self-citationRole of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v95.5.1517.005k48_1517_1532 · Cited by 495
Obesity, haemostasis and the fibrinolytic system
Mertens, I., & Gaal, L. F. V. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00056.x · Cited by 368
Metadata
- Authors
- Behague, I., Poirier, O., Nicaud, V., Evans, A., Arveiler, D., Luc, G., Cambou, J.-P., Scarabin, P.-Y., Bara, L., Green, F., & Cambien, F.
- Venue
- Circulation
- Published
- 1996-02
- Volume
- 93
- Issue
- 3
- Pages
- 440-449
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1975015154
- Cited by
- 282
- References
- 36
- FWCI
- 25.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.